Comparison Between Ticagrelor and Clopidogrel Effect on Endothelial, Platelet and Inflammation Parameters in Patients With Stable Coronary Artery Disease and Chronic Obstructive Pulmonary Disease Undergoing PCI

Trial Profile

Comparison Between Ticagrelor and Clopidogrel Effect on Endothelial, Platelet and Inflammation Parameters in Patients With Stable Coronary Artery Disease and Chronic Obstructive Pulmonary Disease Undergoing PCI

Completed
Phase of Trial: Phase II

Latest Information Update: 23 Mar 2017

At a glance

  • Drugs Aspirin (Primary) ; Ticagrelor (Primary) ; Clopidogrel
  • Indications Coronary artery disease
  • Focus Pharmacodynamics
  • Acronyms NATHAN-NEVER
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 23 Mar 2017 Primary endpoint has been met. (Apoptosis rate in HUVEC) as per results published in the Thrombosis and Haemostasis
    • 23 Mar 2017 Results published in the Thrombosis and Haemostasis
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top